Technology

Catalyst Biosciences

$6.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.15%) Today
$0.00 (0.00%) As of 9:32 PM UTC after-hours

Why Robinhood?

You can buy or sell CBIO and other stocks, options, and ETFs commission-free!

About CBIO

Catalyst Biosciences, Inc. Common Stock, also called Catalyst Biosciences, is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA. The listed name for CBIO is Catalyst Biosciences, Inc. Common Stock.

CEO
Nassim Usman
Employees
34
Headquarters
South San Francisco, California
Founded
2015
Market Cap
145.17M
Price-Earnings Ratio
Dividend Yield
Average Volume
256.05K
High Today
$6.85
Low Today
$6.45
Open Price
$6.70
Volume
292.29K
52 Week High
$8.94
52 Week Low
$3.43

Collections

CBIO Earnings

-$1.23
-$0.82
-$0.41
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 18, Pre-Market

You May Also Like

HDELY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure